Sandbox:ab

Revision as of 23:05, 4 September 2020 by Behjat (talk | contribs)
Jump to navigation Jump to search

Hypokalemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hypokalemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Algorithm

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox:ab On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox:ab

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox:ab

CDC on Sandbox:ab

Sandbox:ab in the news

Blogs on Sandbox:ab

Directions to Hospitals Treating Hypokalemia

Risk calculators and risk factors for Sandbox:ab

There are productive measures as secondary prevention of hypokalemia in patients who are susceptible more or have ongoing potassium losses based on their potassium level, including:

  • Prescribe potassium chloride 20 mg BID: Patients with congestive heart failure and edematous conditions such as cirrhosis have to take it regularly
  • Administrate Proton Pomp Inhibitors and H2 blocker drugs. It can inhibit bicarbonate formation in the stomach and its absorption, as well as limiting potassium loss.
  • Prescribe potassium-sparing medications, such as Amiloride 1.25-2.5 mg BID


Prevention of hypokalemia in patients using diuretics:

  • Administering K-sparing diuretics is the most suitable preventive option. However, hyperkalemia should be considered in patients with diabetes and older cases (PMID: 11539714)

References


Template:WH Template:WS